PSMA binding ligand-linker conjugates and methods for using
US9951324B2 · kind B2 · utility
31Cited by
111References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2016 |
| Grant date | Apr 24, 2018 |
| Priority date | — |
| Expiry date | Feb 8, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/17021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical compositions containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.